Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-18

Clinical Trial Update: Role of Amlodipine in Reduction of CIN [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports an early-phase study evaluating whether amlodipine can reduce contrast-induced nephropathy (CIN). The trial is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)

Snippet

Sponsor: Minia University | Conditions: Contrast-induced Nephropathy | EARLY_Phase 1 | Status: NOT_YET_RECRUITING